Arteriosclerosis stands as one of the most consequential pathophysiological processes in modern medicine, fundamentally transforming elastic conduits into rigid channels and precipitating widespread cardiovascular morbidity. As a major vascular syndrome that underpins ischemic heart disease, cerebrovascular accidents, and peripheral arterial insufficiency, its understanding bridges classical histology, biomechanical hemodynamics, and modern molecular medicine. Deciphering the cellular pathways, mechanical alterations, and clinical sequelae of arterial hardening remains essential for clinicians, researchers, and public health scholars striving to combat the global burden of vascular disease.
Arteriosclerosis
1. Concise Definition
Arteriosclerosis is a general umbrella term designating the progressive thickening, loss of elasticity, and pathological hardening of the arterial walls throughout the systemic circulation. It encompasses a spectrum of degenerative vascular disorders that collectively diminish arterial compliance, heighten central vascular resistance, and compromise end-organ perfusion.
In pathological terms, the condition represents a structural remodelling process characterized by the disruption of the internal elastic lamina, collagenous fibromuscular proliferation, extracellular matrix expansion, and calcification across varying layers of the vascular wall. Depending on the specific anatomical caliber and layer of the vessel involved, this structural degeneration manifests as distinct histological patterns, ranging from intimal lipid accumulation to medial calcific sclerosis and diffuse arteriolar hyalinization.
From a hemodynamic and clinical perspective, arteriosclerosis diminishes the Windkessel effect—the physiological reservoir capacity of the proximal aorta and large arteries that dampens pulsatile systolic pressure and maintains diastolic coronary perfusion. The resulting increase in pulse pressure, cardiac afterload, and downstream microvascular shearing forces establishes a vicious cycle of endothelial injury, end-organ damage, and multi-system vascular deterioration.
2. Etymology & Linguistic Origin
The term arteriosclerosis derives directly from classical linguistic roots, synthesizing Greek anatomical and pathological terminology. The initial component arises from the Ancient Greek noun artēria (ἀρτηρία), originally referring to an airway, windpipe, or conduit, based on ancient anatomical observations that post-mortem arteries were empty of blood and presumed to transport pneuma or air throughout the corporeal frame. Over time, classical and Renaissance anatomical treatises repurposed artēria strictly to describe the pulsating vascular vessels transporting oxygenated systemic blood away from the heart.
The terminal element is derived from the Greek adjective sklēros (σκληρός), signifying “hard,” “indurated,” or “stiff,” fused with the pathological suffix -osis (-ωσις), denoting an abnormal state, morbid process, or degenerative condition. Consequently, the literal etymological formulation translates precisely as “the abnormal hardening or induration of the arteries.”
The compound medical designation entered mainstream European pathological nomenclature during the early nineteenth century. French pathologist and surgeon Jean Lobstein coined the term in his 1833 treatise Traité d’Anatomie Pathologique to describe non-inflammatory, ossified, and fibrotic degeneration of the human arterial wall, distinguishing it from inflammatory arteritis and providing an overarching category that modern vascular medicine retains today.
3. Pronunciation & Grammatical Form
Arteriosclerosis is pronounced phonetically as /ɑːrˌtɪəri.oʊ.skləˈroʊ.sɪs/ in General American English and /ɑːˌtɪə.ri.əʊ.skləˈrəʊ.sɪs/ in British Received Pronunciation. Stress falls primarily on the penultimate syllable of the suffix complex (“-ro-“) with secondary stress allocated to the initial syllable of the root (“-teer-“).
Grammatically, the term functions as an uncountable noun in academic and clinical prose. Its adjectival derivative is arteriosclerotic (/ɑːrˌtɪərioʊskləˈrɒtɪk/), employed to modify anatomical structures, pathological processes, or clinical manifestations (e.g., “arteriosclerotic cardiovascular disease,” “arteriosclerotic retinopathy”). While pluralization is rare due to the abstract nature of the pathological entity, the Latinized plural arterioscleroses is occasionally deployed in comparative histopathological literature to distinguish among multiple divergent morphological subtypes.
4. Detailed Conceptual Explanation
Understanding arteriosclerosis demands recognizing that the human arterial tree is not an inert plumbing network, but a highly dynamic, biomechanically active tissue governed by intricate mechanotransduction and neurohumoral signaling. Arterial walls consist of three distinct tunics: the inner tunica intima, lined with an active monolayer of endothelial cells; the middle tunica media, rich in vascular smooth muscle cells (VSMCs), elastin fibers, and extracellular matrix; and the outer tunica adventitia, populated by fibroblasts, microvascular pericytes, and the vasa vasorum. Arteriosclerosis fundamentally disturbs the delicate biological equilibrium between these tunics.
The physiological hallmark of young, healthy conduit arteries is arterial compliance. During ventricular systole, the proximal aorta distends to absorb approximately fifty percent of the cardiac stroke volume, mitigating high peak systolic pressure. During diastole, the elastic recoil of the aortic wall propels this stored volume forward into peripheral tissues, ensuring sustained coronary and systemic perfusion while arterial pressure falls smoothly. In arteriosclerosis, the repetitive mechanical strain of hundreds of millions of cardiac cycles over decades causes biochemical fatigue of the resilient elastin lamellae. Uncoiled, fractured elastin fibers are progressively replaced by stiff, disorganized fibrillar collagen types I and III, directly degrading this Windkessel function.
At the biochemical and cellular level, this mechanical fatigue is accelerated by persistent systemic insults, including reactive oxygen species, chronic low-grade inflammation, and advanced glycation end-products (AGEs). AGEs form non-enzymatic covalent cross-links between long-lived structural proteins like collagen and elastin, rendering them recalcitrant to physiological enzymatic turnover by matrix metalloproteinases. Simultaneously, vascular smooth muscle cells undergo phenotypic switching from a quiescent, contractile phenotype to a synthetic, proliferative state, secreting abnormal extracellular matrix components and actively regulating osteochondrogenic calcification within the medial layer.
The downstream consequences of this structural stiffening are profound. Pulse wave velocity increases dramatically, meaning that arterial pressure waves travel rapidly to peripheral vascular bifurcation points and reflect backward toward the heart prematurely. In a compliant system, the reflected wave returns during diastole, beneficially augmenting coronary arterial filling. In an arteriosclerotic vascular bed, the reflected wave arrives prematurely during late systole, substantially augmenting aortic peak systolic pressure, exacerbating left ventricular afterload, promoting concentric myocardial hypertrophy, and paradoxically dropping diastolic pressure, which impairs subendocardial coronary perfusion.
5. Historical Development
The historical exploration of arterial degeneration spans millennia, transitioning from ancient post-mortem observations to contemporary genomic and molecular mapping. Ancient Egyptian mummies from the 18th Dynasty (circa 1500 BCE) have provided some of the earliest paleopathological proof of arterial hardening, displaying extensive calcification and luminal thickening on modern micro-computed tomography scans, which conclusively disproves the notion that arteriosclerosis is solely a byproduct of modern industrial lifestyles.
During the Renaissance and early modern scientific revolution, anatomical pioneers advanced the morphological understanding of vascular degeneration. Leonardo da Vinci (1452–1519) illustrated aged tortuous arteries and astutely noted that thickening of arterial walls restricted blood passage and contributed to the demise of elderly individuals. Centuries later, in 1755, Swiss physician Albrecht von Haller utilized the Greek term atheroma to characterize the soft, porridge-like, paste-filled intimal plaques he observed in dissected human aortas.
The systematization of vascular pathology gained definitive momentum in the nineteenth century. Following Jean Lobstein’s introduction of the term arteriosclerosis in 1833, European pathologists engaged in vigorous debate over the primary inciting lesion. The legendary German cellular pathologist Rudolf Virchow proposed in 1856 that arterial hardening was fundamentally an inflammatory reaction of the vascular wall initiated by mechanical friction, irritation, and lipid exudation. Conversely, Carl von Rokitansky asserted that the condition originated from recurrent fibrin deposition from the blood onto the inner arterial surface, leading to secondary degeneration.
In 1904, German pathologist Felix Marchand introduced the hybrid term atherosclerosis to distinguish degenerative, lipid-rich intimal plaque formation from general non-atheromatous medial calcification, such as the distinct circumferential medial sclerosis documented by Johann Georg Mönckeberg in 1903. In the early twentieth century, Russian experimental pathologist Nikolay Anitschkow established that feeding rabbits a high-cholesterol diet produced arterial lesions mimicking human atheromas, firmly positioning lipid metabolism alongside mechanical strain as an indispensable pillar of vascular pathophysiology.
6. Theoretical Foundations
Several theoretical frameworks explain how dynamic vascular physiology degenerates into the structural rigidity characteristic of arteriosclerosis. Foremost among these is the “Response-to-Injury” hypothesis, originally formulated by Russell Ross and John Glomset in the 1970s and refined over subsequent decades. This framework asserts that mechanical forces, chemical toxins, or metabolic anomalies inflict microscopic insults upon the vascular endothelium. Loss of physiological endothelial integrity triggers platelet adhesion, leukocyte recruitment, cellular migration, and localized matrix secretion, culminating in fibro-proliferative remodeling.
Complementing this cellular perspective is the Biomechanical Fatigue and Hemodynamic Remodeling theory, which frames arteriosclerosis as an inevitable material failure of biological polymers under cyclic mechanical fatigue. Biological elastin exhibits exceptional resilience but has virtually zero metabolic turnover in adult tissues; its half-life approaches four to seven decades. Over billions of cyclical expansions and contractions, repetitive tensile stress initiates mechanical fracture of elastin polymers, shifting the mechanical stress burden to non-compliant collagen fibers. This theoretical model accounts for the age-dependent progression of aortic stiffening even in the complete absence of systemic dyslipidemia or inflammatory atheroma.
A third foundational framework is the Oxidative Stress and Cellular Senescence paradigm. This model explains how systemic metabolic stressors—such as hyperglycemia, elevated angiotensin II, and hyperhomocysteinemia—stimulate vascular nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and uncouple endothelial nitric oxide synthase (eNOS). The resulting deluge of reactive oxygen species inactivates nitric oxide, triggering endothelial dysfunction, promoting vascular smooth muscle senescence, and activating transcription factors such as NF-κB and Runx2, which steer vascular smooth muscle cells toward an osteogenic phenotype capable of producing true bone matrix within the medial wall.
7. Key Components, Types & Dimensions
Arteriosclerosis is not a singular, uniform disease process, but rather a structural classification encompassing three major classical variants, each possessing distinct histological, anatomical, and pathological signatures:
- Atherosclerosis: The most prevalent, clinically hazardous subtype, characterized by the progressive accumulation of lipids, cholesterol crystals, apoptotic cellular debris, and inflammatory foam cells within the tunica intima of large and medium-sized elastic and muscular arteries (such as the aorta, coronaries, carotids, and iliofemoral axes). It features fibro-fatty plaque development, core necrosis, and fibrous cap formation susceptible to rupture and acute thrombosis.
- Mönckeberg’s Arteriosclerosis (Medial Calcific Sclerosis): A distinct morphological degenerative pattern involving widespread calcification and ossification of the tunica media in medium-to-small muscular arteries (frequently the femoral, tibial, radial, and uterine arteries), occurring predominantly in elderly individuals, patients with end-stage renal disease, and those with long-standing diabetes. Crucially, the calcific deposits do not impinge directly on the vessel lumen, preserving luminal patency while rendering the artery rigid, non-compressible, and lead-pipe-like.
- Arteriolosclerosis: A condition exclusively affecting small resistance arteries and arterioles (luminal diameter typically under 100 micrometers), classically categorized into two subtypes:
- Hyaline Arteriolosclerosis: Characterized by diffuse, homogeneous, eosinophilic proteinaceous thickening of the arteriolar wall with luminal narrowing, arising from endothelial leakage of plasma proteins and excessive basement membrane matrix production; typically seen in chronic essential hypertension and diabetic microangiopathy.
- Hyperplastic Arteriolosclerosis: Characterized by prominent, concentric, laminated “onion-skin” proliferation of smooth muscle cells and duplicated basement membranes in response to severe, acute elevations in systemic arterial pressure, typical of malignant or accelerated hypertension, often accompanied by necrotizing arteriolitis.
8. Examples & Illustrative Cases
The clinical presentation of arteriosclerosis varies depending on the affected arterial beds and the structural subtype involved. In an archetypal presentation of age-related aortic arteriosclerosis, a 74-year-old patient presents for a routine wellness evaluation. Physical assessment reveals an isolated systolic hypertension of 172/64 mmHg, yielding a pulse pressure of 108 mmHg. Auscultation uncovers a harsh, early-systolic ejection murmur over the right upper sternal border. Echocardiography demonstrates concentric left ventricular hypertrophy with preserved ejection fraction and evidence of early diastolic dysfunction. The structural stiffening of the thoracic aorta has degraded its Windkessel properties, amplifying reflected pressure waves back to the heart during systole, elevating systolic afterload and myocardial oxygen consumption while leaving diastolic perfusion pressure compromised.
In a contrasting scenario illustrating Mönckeberg’s medial calcific sclerosis, a 68-year-old patient with a 25-year history of poorly controlled type 2 diabetes and diabetic nephropathy presents with ischemic ulcerations on the distal phalanges of the left foot. Upon non-invasive vascular evaluation, the calculated ankle-brachial index (ABI) yields a falsely elevated, non-physiological reading of 1.55 (normal range: 0.90–1.30). Plain radiography of the lower extremity demonstrates continuous, circumferential, “tram-track” calcification running unbroken along the posterior tibial and dorsalis pedis arteries. The arterial media has fully calcified, rendering the vessels completely resistant to external pneumatic cuff compression and generating misleadingly elevated automated pressure readings despite genuine distal tissue ischemia.
A third clinical manifestation involves advanced arteriolar sclerosis in the setting of chronic renal disease. A 58-year-old with longstanding essential hypertension develops progressive, silent proteinuria and an elevated serum creatinine. A renal core needle biopsy reveals extensive hyaline arteriolosclerosis involving the afferent arterioles, with pronounced lumen stenosis, downstream glomerular ischemic collapse, tubular atrophy, and interstitial fibrosis. Here, the primary defect resides in the microvascular resistance vessels, driving progressive hypertensive nephrosclerosis through chronic parenchymal underperfusion.
9. Measurement & Assessment
Assessing arteriosclerosis combines non-invasive hemodynamic measurements, physiological biomarkers, and sophisticated radiological imaging to evaluate both the functional stiffness and the morphological anatomy of the arterial wall.
The clinical and epidemiological gold standard for quantifying arterial stiffness is carotid-femoral pulse wave velocity (cfPWV). Utilizing transcutaneous applanation tonometry or Doppler ultrasound probes placed simultaneously or sequentially over the common carotid and femoral arteries, clinicians measure the transit time of the cardiac arterial pulse wave over a measured surface distance. A cfPWV value exceeding 10 meters per second denotes marked central aortic stiffness and serves as an independent predictor of adverse cardiovascular outcomes.
Complementary hemodynamic indices include Pulse Wave Analysis (PWA), which measures the augmentation index (AIx)—a parameter reflecting the proportion of central pulse pressure attributable to the reflected wave returning prematurely to the ascending aorta. In parallel, the ankle-brachial index (ABI) provides rapid assessment of peripheral arterial compressibility and flow obstruction; values below 0.90 indicate atherosclerotic stenosis, whereas values above 1.40 indicate non-compressible, calcified medial sclerosis.
Radiological and morphological evaluation involves high-resolution modalities. B-mode ultrasound enables precise measurement of the carotid Intima-Media Thickness (cIMT), an established surrogate marker of structural remodeling and subclinical atherogenesis. Non-contrast cardiac computed tomography evaluates coronary artery calcium (CAC) scoring via the Agatston method, providing a quantified, validated assessment of total calcified plaque burden. Contrast-enhanced computed tomography angiography (CTA) and magnetic resonance angiography (MRA) further characterize luminal narrowing, wall thickness, and arterial wall geometry throughout the cerebrovascular, thoracic, abdominal, and peripheral vascular territories.
10. Applications & Practical Significance
The practical applications of recognizing and measuring arteriosclerosis cross multiple fields of clinical medicine, public health, and therapeutics. In cardiovascular risk stratification, quantifying arterial stiffness through cfPWV or CAC scoring allows clinicians to reclassify patients initially categorized as “intermediate risk” by traditional risk calculators (such as the Framingham Risk Score or the ACC/AHA Pooled Cohort Equations) into definitive high-risk tiers, prompting earlier and more aggressive lipid-lowering, anti-inflammatory, and antihypertensive interventions.
In pharmacological management, recognizing that isolated systolic hypertension in older populations stems from structural arteriosclerosis rather than simple hypervolemia or peripheral vasoconstriction guides therapeutic selection. Antihypertensive agents that attenuate wave reflections and improve vascular compliance—such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and long-acting dihydropyridine calcium channel blockers—are prioritized over non-vasodilating beta-blockers, which can paradoxically increase central wave augmentation by prolonging the cardiac ejection period.
In surgical and interventional disciplines, recognizing extensive medial calcific sclerosis is vital prior to peripheral revascularization. Heavily calcified, non-compliant vessels pose severe challenges during balloon angioplasty, often requiring specialized intravascular lithotripsy, rotational atherectomy, or bypass surgery. Furthermore, in clinical nephrology and transplantation medicine, systemic arteriosclerosis dictates dialysis vascular access planning; severely calcified radial or brachial vessels frequently preclude successful autogenous arteriovenous fistula maturation, necessitating alternative access strategies.
11. Research & Empirical Evidence
Decades of large-scale epidemiological and basic science research have validated the pathological trajectory of arterial hardening and established its status as a leading determinant of cardiovascular mortality, as highlighted by continuous global monitoring from the World Health Organization.
The seminal Framingham Heart Study provided transformative longitudinal evidence demonstrating that as individuals age, diastolic blood pressure plateaus and gradually declines while systolic pressure climbs inexorably. This widened pulse pressure—a direct clinical surrogate for advancing central arteriosclerosis—was definitively established by researchers such as William B. Kannel and his colleagues as a more powerful independent predictor of coronary artery disease, stroke, and heart failure in older adults than mean arterial pressure or diastolic pressure alone.
In a landmark 2006 meta-analysis published in the European Heart Journal, Jacques Blacher, Stéphane Laurent, and collaborators demonstrated that elevated aortic pulse wave velocity represents an independent predictor of all-cause and cardiovascular mortality in patients with hypertension, diabetes, and end-stage renal disease, as well as in the general population. Their findings highlighted that for every 1 m/s increase in cfPWV, the risk of a major cardiovascular event increases by approximately fifteen percent, independent of standard vascular risk factors.
On the molecular level, landmark trials such as the CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study), led by Paul Ridker in 2017, provided conclusive clinical proof that targeted anti-inflammatory therapy directed at interleukin-1β (IL-1β) reduces recurrent cardiovascular events in patients with prior myocardial infarction and elevated high-sensitivity C-reactive protein, without altering lipid concentrations. This confirmed decades of laboratory hypotheses proving that systemic and vascular wall inflammation actively drives the clinical progression and destabilization of arteriosclerotic vascular lesions.
12. Cultural & Cross-Cultural Considerations
The prevalence, phenotypic presentation, and progression of arteriosclerosis exhibit significant geographical, cultural, and socioeconomic variation globally. Historically documented in the classic Seven Countries Study directed by Ancel Keys in the mid-twentieth century, populations adhering to traditional Mediterranean dietary patterns rich in monounsaturated fats, polyphenols, and fresh produce exhibited markedly lower rates of arteriosclerotic cardiovascular mortality compared to cohorts consuming diets dense in processed meats and refined saturated fats.
Sociodemographic transitions across low- and middle-income countries have catalyzed an accelerated vascular disease burden. Rapid urbanization, sedentary lifestyles, industrial dietary shifts, and elevated tobacco consumption have produced escalating rates of premature arterial stiffening and microvascular disease in regions previously protected by traditional lifestyles. In South Asian populations, an extensive body of epidemiological literature reveals a heightened genetic and epigenetic susceptibility to accelerated atherosclerosis, marked by premature onset, diffuse multi-vessel involvement, smaller caliber coronary arteries, and elevated lipoprotein(a) concentrations.
Cross-cultural discrepancies in healthcare delivery, early screening infrastructure, and access to essential antihypertensive therapies further widen global disparities in arteriosclerotic outcomes. While high-income countries have observed a steady decline in age-adjusted arteriosclerotic cardiovascular mortality through widespread deployment of statins and blood pressure regimens, low-resource settings face a compounding double burden: infectious illnesses alongside an epidemic of undetected, unmanaged arterial hypertension driving accelerated vascular disease and early stroke.
13. Criticisms, Debates & Limitations
Despite centuries of scientific investigation, considerable debate persists regarding the taxonomy, primary causal drivers, and optimal management of arteriosclerosis. A central, longstanding conceptual conflict involves the widespread conflation of the terms arteriosclerosis and atherosclerosis. In clinical practice and academic literature alike, clinicians frequently use the two terms interchangeably. Purists and cardiovascular pathologists argue that this loose terminology obscures essential mechanistic differences, inappropriately equating focal intimal lipid-driven atheroma with diffuse, non-atheromatous medial calcification or microvascular arteriolar hyalinization.
Another contentious debate revolves around the “Cholesterol Hypothesis” versus the “Inflammatory/Endothelial Paradigm.” While lipid-lowering therapies (specifically statins and PCSK9 inhibitors) have consistently demonstrated reductions in ischemic cardiovascular events, a substantial residual risk remains in patients who achieve ultra-low LDL cholesterol targets. This discordance has spurred debate over whether cholesterol deposition is a true primary cause or an opportunistic passenger infiltrating an already chronically inflamed, biomechanically damaged, and dysfunctional endothelial barrier.
Finally, there is ongoing critical discourse regarding whether vascular stiffening and medial calcification represent an inevitable, immutable biological consequence of senescence—a physiological “graying of the arteries”—or a preventable, reversible disease state. While contemporary pharmaceutical agents can effectively manage blood pressure and reduce lipid levels, pharmacologically reversing structural cross-linked collagen or decalcifying ossified medial layers remains a largely unrealized clinical goal, exposing a fundamental limitation in current vascular therapeutics.
14. Related Terms & Distinctions
Clear diagnostic and academic discourse requires careful distinction between arteriosclerosis and closely aligned clinical entities:
- Atherosclerosis: A specific subcategory of arteriosclerosis characterized by the focal development of fibro-fatty atheromatous plaques within the intimal layer of large and medium arteries; unlike generic arteriosclerosis, it involves lipid accumulation, core necrosis, and high risk of plaque rupture.
- Arteriolosclerosis: Hardening, hyaline deposition, or muscular hyperplastic thickening restricted exclusively to small resistance arteries and arterioles; it damages the microvasculature rather than conduit vessels.
- Arteritis: Primary inflammatory inflammation of the arterial wall (such as Giant Cell Arteritis or Takayasu’s Arteritis) characterized by active autoimmune leukocyte infiltration, distinct from the non-immune fibro-calcific remodeling of arteriosclerosis.
- Mönckeberg’s Sclerosis: Medial calcification that hardens the muscular layers of medium arteries without producing luminal narrowing or thrombus formation; in contrast, atherosclerosis causes eccentric luminal encroachment and thromboembolic occlusion.
- Arterial Compliance: The physiological capacity of a vessel to expand and contract in response to dynamic pressure fluctuations; it serves as the physiological inverse of arterial stiffness.
15. Summary & Key Takeaways
Arteriosclerosis represents a multifaceted spectrum of non-inflammatory degenerative alterations in the arterial tree, resulting in arterial thickening, calcification, and a critical loss of vascular elasticity. Encompassing distinct pathophysiological variants—including atherosclerosis, Mönckeberg’s medial calcific sclerosis, and arteriolar sclerosis—it affects vessels of all calibers through a shared interplay of mechanical fatigue, endothelial dysfunction, vascular smooth muscle transformation, and chronic cellular senescence.
The loss of physiological arterial compliance impairs the Windkessel effect, heightening systemic pulse pressure, augmenting cardiac afterload, and accelerating downstream end-organ damage across the brain, heart, and kidneys. Accurate assessment requires integrating non-invasive functional tools such as carotid-femoral pulse wave velocity with structural imaging such as coronary artery calcium scoring and vascular ultrasound. Effective intervention depends on early risk stratification, aggressive management of modifiable metabolic and hemodynamic risk factors, and therapeutic strategies that restore endothelial homeostatic balance.
Ultimately, arteriosclerosis is not a localized structural anomaly, but a comprehensive indicator of biological aging and systemic vascular health. As the global population ages and the prevalence of cardiometabolic risk factors escalates, uncovering the precise cellular, genetic, and biomechanical drivers of arterial hardening remains one of the primary frontiers of preventive cardiovascular medicine.
References
- Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999). Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension, 33(5), 1111–1117. https://www.ahajournals.org/doi/10.1161/01.hyp.33.5.1111
- Kannel, W. B., Gordon, T., & Schwartz, M. J. (1971). Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham study. The American Journal of Cardiology, 27(4), 335–346. https://doi.org/10.1016/0002-9149(71)90428-0
- Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., & Struijker-Boudier, H. (2006). Expert consensus document on arterial stiffness: Methodological issues and clinical applications. European Heart Journal, 27(21), 2588–2605. https://doi.org/10.1093/eurheartj/ehl254
- Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J. J. P., Cornel, J. H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., … Libby, P. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine, 377(12), 1119–1131. https://doi.org/10.1056/NEJMoa1707914
- Ross, R. (1999). Atherosclerosis — An inflammatory disease. The New England Journal of Medicine, 340(2), 115–126. https://doi.org/10.1056/NEJM199901143400207